Ipilimumab and Stereotactic Radiosurgery with CyberKnife<sup>®</sup> System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience
The median overall survival (OS) and local control (LC) of patients with melanoma brain metastases (MBMs) are poor even with immune checkpoint inhibitors and/or radiotherapy (RT). The aims of the study were to evaluate the association and timing of stereotactic radiotherapy (SRT)/radiosurgery (SRS)...
Main Authors: | Valentina Borzillo, Rossella Di Franco, Diana Giannarelli, Fabrizio Cammarota, Esmeralda Scipilliti, Emma D'Ippolito, Angela Petito, Marcello Serra, Sara Falivene, Antonio M. Grimaldi, Ester Simeone, Lucia Festino, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Gabriele Madonna, Paolo A. Ascierto, Paolo Muto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1857 |
Similar Items
-
Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use
by: Ascierto Paolo A, et al.
Published: (2012-05-01) -
Hearing preservation after cyberknife stereotactic radiosurgery for vestibular schwannomas
by: Shao-Wei Feng, et al.
Published: (2019-01-01) -
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab
by: Gabriele Madonna, et al.
Published: (2018-12-01) -
Treat high cervical spinal arteriovenous malformation with Cyberknife radiosurgery
by: Yu-Fen Huang, et al.
Published: (2014-01-01) -
Preliminary Effect of Cyberknife Radiosurgery in the Treatment of 31 Patients with Advanced Non-small Cell Lung Cancer
by: Yanling LV, et al.
Published: (2011-04-01)